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Abstract: Blood–brain barrier (BBB) disruption is a critical event after ischemic stroke, which
results in edema formation and hemorrhagic transformation of infarcted tissue. BBB dysfunction
following stroke is partly mediated by proinflammatory agents. We recently have shown that high
frequency stimulation of the mesencephalic locomotor region (MLR-HFS) exerts an antiapoptotic
and anti-inflammatory effect in the border zone of cerebral photothrombotic stroke in rats. Whether
MLR-HFS also has an impact on BBB dysfunction in the early stage of stroke is unknown. In this
study, rats were subjected to photothrombotic stroke of the sensorimotor cortex and implantation of a
stimulating microelectrode into the ipsilesional MLR. Thereafter, either HFS or sham stimulation of
the MLR was applied for 24 h. After scarifying the rats, BBB disruption was assessed by determining
albumin extravasation and tight junction integrity (claudin 3, claudin 5, and occludin) using Western
blot analyses and immunohistochemistry. In addition, by applying zymography, expression of
pro-metalloproteinase-9 (pro-MMP-9) was analyzed. No differences were found regarding infarct size
and BBB dysfunction between stimulated and unstimulated animals 24 h after induction of stroke.
Our results indicate that MLR-HFS neither improves nor worsens the damaged BBB after stroke.
Attenuating cytokines/chemokines in the perilesional area, as mediated by MLR-HFS, tend to play a
less significant role in preventing the BBB integrity.
Keywords: photothrombotic stroke; deep brain stimulation; mesencephalic locomotor region;
blood-brain barrier; tight junctions
1. Introduction
After cerebral ischemia, a large number of pathological processes in the microvasculature contribute
to the evolution of infarction [1]. A key factor in this context is the breakdown of the blood–brain barrier
(BBB) [2], which affects further homoeostasis of ischemic tissue and entails serious clinical events such
as hemorrhagic transformation [3]. The BBB consists of brain endothelial cells and pericytes, as well
as astrocyte end-feet, and thus, is a highly complex interface between circulating blood and brain
parenchyma [4]. Animal models of acute ischemic stroke have shown a timeline for breakdown of
the BBB: After interruption of blood supply, an increasing permeability of BBB was observed [2,5].
However, when reperfusion was allowed early, BBB integrity recovered to a certain extent, before a
delayed secondary chronic opening of the BBB occurred as a result of an inflammatory response to
the ischemic cerebral tissue 24 to 72 h after stroke onset [2]. These findings were corroborated by a
recently published study demonstrating that mild disruption of the BBB in stroke survivors is reversible
with reperfusion [6]. Thus, the question rises whether targeting BBB dysfunction in the perilesional
area of a cerebral ischemia might be a treatment option for ischemic stroke. However, approved
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pharmacological treatments to prevent BBB after ischemic stroke are not available so far. Interestingly,
nonpharmacological approaches, such as electrical stimulation of the sphenopalatine ganglion in a
photothrombotic stroke model or deep brain stimulation (DBS) of the anterior thalamic nuclei, reduced
BBB leakage [7,8]. These findings might be explained by an attenuated cerebral inflammation or change
of the cerebral microvasculature due to electrical modulation of the parasympathetic innervation.
Recently, we have shown that DBS of the mesencephalic locomotor region (MLR) improves gait
function [9], but also reduces inflammatory processes in the perilesional area of a photothrombotic
stroke model [10]. The MLR is a functionally defined region of the brainstem encompassing the
cuneiform, pedunculopontine tegmental, and mesencephalic reticular nucleus [11], which is connected
indirectly with the cerebral cortex. We hypothesize that high frequency stimulation (HFS) of the MLR
might also result in a reduction of BBB disruption due to the attenuated perilesional inflammation, and
thus, investigated in the present study whether MLR-HFS: (i) reduces the extravasation of albumin; (ii)
decreases the degradation of tight junction molecules, i.e., claudin 3, claudin 5, and occludin; and (iii)
reduces the expression of pro-MMP-9.
2. Results
2.1. MLR-HFS Does Not Change BBB Leakage and Albumin Extravasation
First, infarct volumes were assessed by planimetric analysis of DAPI-stained brain sections of the
two groups. Both the sham as well as the stimulated group showed a similar size of infarct volume
within the sensorimotor cortex (stim vs. sham: 19.8 ± 1.2% vs. 20.7 ± 2.0%; p > 0.05) (Figure 1C).
In the next set of experiments, we investigated immunohistochemically whether MLR-HFS in
rats has an impact (i) on BBB leakage in the perilesional area and (ii) on global BBB integrity, i.e., in
vessel territories remote from the photochemically induced stroke, as previously reported [5]. Albumin
extravasation as a result of BBB leakage was assessed by planimetry in sham-stimulated rats and in rats
undergoing MLR-HFS for 24 h, beginning 3 h after induction of photothrombotic stroke. Both the sham
and the stimulated group showed a similar albumin-positive area within the ischemic hemispheres
(stim vs. sham: 8.8 ± 1.9% vs. 7.5 ± 1.9%; p > 0.05), in particular, they did not differ regarding BBB
disruption in the area surrounding the photothrombotic lesion (Figure 1A,B).
In a further step, albumin extravasation was examined in the perilesional cortical area as well as in
the basal ganglial region using Western blot. This analysis confirmed the aforementioned histological
examination: The amount of albumin was significantly increased in the ipsilesional hemisphere, being
indicative of post-ischemic BBB disruption. This finding reaffirmed that MLR-HFS did not alter the
albumin content neither in the cortical (ipsi: Stim vs. sham: 0.87 ± 0.09 vs. 0.95 ± 0.12; p > 0.05) nor in
the basal ganglial region (ipsi: Stim vs. sham: 0.63 ± 0.10 vs. 0.75 ± 0.16; p > 0.05) (Figure 1A–E).
2.2. MLR-HFS Does Not Influence Degradation of Tight Junction Molecules
To assess whether MLR-HFS applied for 24 h protects tight junction molecules from degradation
after photothrombotic stroke, occludin, claudin 3, and claudin 5 protein expressions were quantified
in cortical and basal ganglial samples using Western blot analysis. In both the stimulated and sham
groups, expression of occludin, claudin 3, and claudin 5 was clearly diminished in the perilesional
cortex compared to the corresponding region of the contralateral hemisphere. When comparing the
perilesional cortex of both groups, no significant difference was detectable regarding the expression of
these tight junction proteins (occludin, stim vs. sham: 0.51 ± 0.11 vs. 0.53 ± 0.10, p > 0.05; claudin 5,
stim vs. sham: Beyond detection level; claudin 3, stim vs. sham: 0.23 ± 0.03 vs. 0.19 ± 0.02, p > 0.05)
(Figure 2A,C,E). The same was true for expression levels of occludin, claudin 3, and claudin 5 in the
basal ganglia regions (occludin, stim vs. sham: 0.68 ± 0.09 vs. 0.72 ± 0.13, p > 0.05; claudin 5, stim vs.
sham: 1.12 ± 0.07 vs. 1.11 ± 0.11, p > 0.05; claudin 3, stim vs. sham: 0.54 ± 0.05 vs. 0.62 ± 0.09, p > 0.05)
(Figure 2B,D,F).
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Figure 1. Stimulation of the mesencephalic locomotor region (MLR) in the acute phase after
photothrombotic stroke does not alter albumin extravasation and lesion size. (A) Representative
immunocytologic staining of albumin within the cortical ischemic penumbra of a high-frequency
stimulated (stim) and an unstimulated (sham) rat. (B) Quantification revealed comparable
albumin-positive areas in the ipsilesional hemispheres of unstimulated (sham) and high-frequency
stimulated (stim) rats 27 h after photothrombosis (n = 6–8/group). Unpaired, two-tailed Student’s t-test.
(C) Infarct volumes are similar (n = 6–8/group) between the two treatment groups. Unpaired, two-tailed
Student’s t-test. (D,E), Representative anti-albumin Western blot analysis (cc, cortex contralesional; ci,
cortex ipsilesional; bgc, basal ganglia contralesional; bgi, basal ganglia ipsilesional) and densitometric
quantification of albumin protein expression in the basal ganglial as well as cortical regions 27 h after
photothrombosis within the two treatment groups (n = 5–7/group). One-way ANOVA, and unpaired,
two-tailed Student’s t-test. * p < 0.05; ** p < 0.01; *** p < 0.001.Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 5 of 11 
 
 
Figure 2. Stimulation of the mesencephalic locomotor region does not modulate 
photothrombosis-driven tight junction protein degradation. (A,B), Representative anti-occludin 
Western blot analysis (cc, cortex contralesional; ci, cortex ipsilesional; bgc, basal ganglia 
contralesional; bgi, basal ganglia ipsilesional) and densitometric quantification of occludin protein 
expression in the basal ganglial as well as cortical regions 27 h after photothrombosis of unstimulated 
(sham) and high-frequency stimulated (stim) rats (n = 5–7/group). One-way ANOVA. * p < 0.05; ** p < 
0.01. (C,D), Representative anti-claudin 5 Western blot analysis (cc, cortex contralesional; ci, cortex 
ipsilesional; bgc, basal ganglia contralesional; bgi, basal ganglia ipsilesional; bd, beyond detection 
limit) and densitometric quantification of claudin 5 protein expression in the basal ganglial as well as 
cortical regions 27 h after photothrombosis within the two treatment groups (n = 5–7/group). 
One-way ANOVA. (E,F), Representative anti-claudin 3 Western blot analysis (cc, cortex 
contralesional; ci, cortex ipsilesional; bgc, basal ganglia contralesional; bgi, basal ganglia ipsilesional; 
bd, beyond detection limit) and densitometric quantification of claudin 3 protein expression in the 
basal ganglial as well as cortical regions 27 h after photothrombosis within the two treatment groups 
(n = 5–7/group). One-way ANOVA. *** p < 0.001. 
Next, we applied immunostaining for claudin 5 and occludin to visualize the current state of 
the vasculature and to provide a detailed insight into the extent of the BBB disruption in the 
perilesional area. In line with our Western blot analysis, claudin 5 and occludin morphology was 
clearly changed in the perilesional cortex compared to control, whereas the comparison of the two 
groups revealed no differences (claudin 5, stim vs. sham: 13.55 ± 2.25  vs. 13.71 ± 4.03, p > 0.05; 
occludin, stim vs. sham: 12.03 ± 2.78  vs. 11.91 ± 1.74, p > 0.05), (Figure 3A–E). Importantly, 
degradation of tight junctions within the ischemic penumbra was accompanied by the activation of 
endothelial cells, as indicated by a massive change of vWF distribution/expression. Again, no 
difference became apparent in stimulated and sham-stimulated animals (Figure 3F). 
Figure 2. Cont.
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Figure 2. Stimulation of the mesencephalic locomotor region does not modulate photothrombosis-driven
tight junction protein degradation. (A,B), Representative anti-occludin Western blot analysis (cc, cortex
contralesional; ci, cortex ipsilesional; bgc, basal ganglia contralesional; bgi, basal ganglia ipsilesional)
and densitometric quantific tion of occludin protein expression in the basal ga glial as well as cortical
regions 27 h after p otothrombosis of unstimulated (sham) and high-frequency stimulated (stim) rats
(n = 5–7/group). One-way ANOVA. * p < 0.05; ** p < 0.01. (C,D), Repr sentative anti-claudin 5 Western
blot analysis (cc, cortex contralesional; ci, cortex ipsilesional; bgc, basal ganglia contralesional; bgi,
basal ganglia ipsilesional; bd, beyond detection limit) and densitometric quantification of claudin 5
protein expression in the basal ganglial as well as cortical regions 27 h after photothrombosis within the
two treatment groups (n = 5–7/group). One-way ANOVA. (E,F), Representative anti-claudin 3 Western
blot analysis (cc, cortex contralesional; ci, cortex ipsilesional; bgc, basal ganglia contralesional; bgi,
basal ganglia ipsilesional; bd, beyond detection limit) and densitometric quantification of claudin 3
protein expression in the basal ganglial as well as cortical regions 27 h after photothrombosis within the
two treatment groups (n = 5–7/group). One-way ANOVA. *** p < 0.001.
Next, we applied immunostaining for claudin 5 and occludin to visualize the curre t t t f the
vasculature and to provide a detail d insight into the ex en of the BBB disruption in the perilesional
area. In line with our Western blot analysis, claudin 5 and occl din morphology was clearly changed
in the perilesional cortex compared to control, whereas the comparison of the two groups revealed
no differences (claudin 5, stim vs. sham: 13.55 ± 2.25 vs. 13.71 ± 4.03, p > 0.05; occludin, stim vs.
sham: 12.03 ± 2.78 vs. 11.91 ± 1.74, p > 0.05), (Figure 3A–E). Importantly, degradation of tight junctions
within the ischemic penumbra was accompanied by the activation of endothelial cells, as indicated by
a massive change of vWF distribution/expression. Again, no difference became apparent in stimulated
and sham-stimulated animals (Figure 3F).
2.3. MLR-HFS Does Not Affect Matrix Metalloproteinase-9 Expression after Photothrombosis
To assess whether MLR-HFS applied for 24 h has an impact on metalloproteinases after
photothrombotic stroke, pro-MMP-9 protein expression was quantified in cortical samples using
zymography. In both stimulated and sham-stimulated animals, expression of pro-MMP-9 was
clearly increased in the perilesional cortex compared to the corresponding region of the contralateral
hemisphere. When comparing the perilesional cortex of both groups, no difference was found (stim vs.
sham: 15.4 ± 2.3 vs. 11.8 ± 1.6, p > 0.05) (Figure 4A,B).Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 6 of 11 
 
 
Figure 3. Stimulation of the mesencephalic locomotor region does not modulate 
photothrombosis-driven tight junction morphology and endothelial activation. (A) Representative 
immunocytologic staining of von Willebrand factor (vWF) in the ischemic hemisphere 27 h after 
photothrombosis within the two treatment groups. The dashed line indicates the border to the 
photothrombotic stroke (lesional) (Scale bar: 200 µm). (B–E) Representative images of anti-claudin 5 
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2.3. MLR-HFS Does Not Affect Matrix Metalloproteinase-9 Expression after Photothrombosis 
To assess whether MLR-HFS applied for 24 h has an impact on metalloproteinases after 
photothrombotic stroke, pro-MMP-9 protein expression was quantified in cortical samples using 
zymography. In both stimulated and sham-stimulated animals, expression of pro-MMP-9 was 
clearly increased in the perilesional cortex compared to the corresponding region of the contralateral 
hemisphere. When comparing the perilesional cortex of both groups, no difference was found (stim 
vs. sham: 15.4 ± 2.3 vs 11.8 ± 1.6, p > 0.05) (Figure 4 A,B). 
Figure 3. Cont.
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Figure 3. Stimulation of the mesencephalic locomotor region does not modulate photothrombosis-driven
ti ht junction morphol gy and endothelial activation. (A) Representative immunocytol gic staining of
von Willebrand factor (vWF) in the ischemic hemisphere 27 h after pho othr mbosis within the two
treatment groups. The dashed line indicates the border to the photothrombotic stroke (lesional) (Scale
bar: 200 µ ). (B–E) Represen ative images of anti-claudin 5 and anti-occlu n immunohistochemistry
in the ipsilatateral (lesional or control) are and quantification of the mean length of the tight j nction
morphology 27 h after phot thrombosis of unstimulated (sh m) and high-frequency stimul t d (stim)
rats (n = 5–7/group). One-way ANOVA.* p < 0.05; ** p < 0.01; *** p < 0.001. (Scale bar: 25 µm). (F)
Representative anti-vWF staining in the ipsilesional hemisphere 27 h after photothrombosis within the
two treatment groups (Scale bar: 25 µm).
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Figure 4. Stimulation of the mesencephalic locomotor region does not modulate photothrombosis-driven
pro-matrix metalloproteinase (MMP)-9 expression. (A,B) Representative experiment of zymography
bands (cc, cortex contralesional; ci, cortex ipsilesiona; bd, beyond detection limit) and densitometric
quantification of pro-MMP-9 expression in the cortical regions 27 h after photothrombosis of
unstimulated (sham) and high-frequency stimulated (stim) rats (n = 5–7/group). One-way ANOVA.
3. Discussion
This study yielded the following main findings: MLR-HFS, started three hours after induction of
a photothrombotic stroke in the sensorimotor cortex of rats and applied continuously for 24 h (i) did
not improve nor worsen the hampered BBB due to ischemia; (ii) had no impact n the expression of
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three main components of the BBB—claudin 3, claudin 5, and occludin; and (iii) had no impact on the
expression of pro-MMP-9.
Cerebral ischemia involves different processes that are directed against the BBB integrity, such
as activation of endothelial cells, reactive oxygen species, and finally, oxidative stress resulting in a
loss of tight junctions [2]. In particular, the importance of inflammatory pathways regarding injury
of BBB has been suggested by several studies, whereas chemokines and cytokines are key players in
this context [12,13]. Recently, we have shown that MLR-HFS ipsilateral to the lesion enables restoring
gait impairment in rats with photochemically induced stroke in the sensorimotor cortex [9], but also
attenuates inflammatory processes in the perilesional area when HFS is applied during 24 h in the
early course after induction of photothrombotic stroke [10]. Therefore, we hypothesized that this
anti-inflammatory effect of MLR-HFS might contribute—at least in part—to the stabilization of the
BBB after ischemic stroke. Thus, electrical stimulation would be an alternative to pharmacological
therapies targeting BBB stabilization that failed to show any benefit so far. However, the present
study demonstrated that MLR-HFS does not attenuate BBB dysfunction in the perilesional area, nor in
vessel territories remote from the photothrombotic stroke, as visualized within the basal ganglia. Of
note, BBB disruption was not only restricted to the perilesional area surrounding the photothrombotic
stroke, but was also apparent in more widespread areas when depicted with a sensitive method such
as magnetic resonance imaging with gadoflurine M [5]. In both stimulated and unstimulated animals,
a similar change of tight junctions was recognized in the ipsilesional cortex, whereas an alteration of
tight junctions was not detectable in the basal ganglia of both groups. On the other hand, we found an
increase of albumin in the basal ganglia, independent of electrical stimulation, which might appear
contradictory at first sight in regards to the behavior of tight junctions under ischemic conditions. We
suggest that BBB disruption remote from the photothrombotic stroke is only attenuated, but is severe
enough to open the BBB for proteins of the size of albumin for hours before achieving the initial state
again. However, it is much more likely that BBB damage in the perilesional area results in a major
extravasation of albumin, which is distributed via the extracellular space over time, and thus, is finally
also detectable in the basal ganglia.
In the present study, the effect of MLR-HFS on BBB leakiness after photothromotic stroke was
monitored primarily by detecting the loss of tight junction proteins. The role of claudin 3 in contributing
to the BBB integrity however is controversial: Whereas some authors have shown an impaired BBB
in claudin 3 knockout (KO) mice exhibiting an experimental autoimmune encephalomyelitis [14],
Dias and coworkers found that absence of claudin 3 in KO mice did not alter BBB function during
neuroinflammation in mice [15]. However, whether the same is true in the paradigm of experimental
stroke in rats requires further investigation.
Furthermore, degradation of tight junctions in the area surrounding the photothrombotic stroke
was accompanied by the activation of endothelial cells, as indicated by a massive release of vWF. This
endothelial vWF exocytosis is probably induced by hypoxia, and results in a rapid recruitment of
neutrophils [16,17]. However, this inflammatory phenotype of the BBB obviously cannot be prevented
by electrical stimulation, and thus, is not sufficient enough for structural and functional recovery of
the BBB.
Whether low frequency stimulation is more likely to result in a stabilization of BBB has not been
investigated in this study and has to be addressed in future experiments. Nevertheless, electrical
stimulation appears to allow modulating the BBB, depending on the structure that is stimulated—
recently, Levi and coworkers have reported that low frequency stimulation of the sphenopalatine
ganglion not only diminished infarct volume, but also reduced BBB dysfunction after photothrombotic
stroke in rats [7]. Interestingly, when the same ganglion was stimulated at high intensities, an increased
BBB permeability was observed in rats [18]. The sphenopalatine ganglion—an important source of
parasympathetic innervation to brain vasculature—receives fibers from the brain stem, namely from
the reticular formation [19]. Although there are described connections between the MLR and reticular
formation [20], and vegetative functions of the MLR are known [21], an innervation of the cerebral
Int. J. Mol. Sci. 2019, 20, 4036 7 of 10
vasculature originating from the MLR has not been demonstrated so far. The anterior thalamic nuclei
are another cerebral structure that modulates the BBB: A recently published study reported that after
electrical stimulation of these nuclei, albumin extravasation was decreased in brains of rats [8].
4. Materials and Methods
4.1. Animals
Male Wistar rats (Charles River, Sulzfeld, Germany), 10–12-weeks-old, were acclimatized before
intervention for 1 week in a room of our animal facility with controlled temperature (22 ± 0.5◦C)
under a 12 h/12 h light/dark cycle. They were allowed free access to water and food. All animal
experiments were approved by the institutional review board of the Julius-Maximilians-University,
Würzburg and by the local authorities at the Regierung von Unterfranken, Würzburg, Germany
(TVA55.2-2531.01-102/13; 2 October 2013).
4.2. Induction of Photothrombotic Stroke
All animals were subjected to photothrombotic stroke as described elsewhere in detail [9]. Under
deep anesthesia (isoflurane 2.5% (cp-pharma, Burgdorf, Germany), rats were placed in a stereotactic
frame. A template with an aperture covering the right sensorimotor cortex was put on the exposed
skull (5 mm anterior to 5 mm posterior and 0.5 mm to 5.5 mm lateral to the bregma). Rose Bengal
(Sigma, Darmstadt, Germany) in NaCl 0.9% was administered intravenously and then the sensorimotor
cortex was illuminated with a cold light source (Olympus KL1500LCD, Main, Germany) for 15 min.
4.3. Microelectrode Implantation
Immediately after induction of photothrombosis, a monopolar electrode was implanted in the
ipsilateral MLR (7.8 mm posterior, 2.0 mm lateral and 5.8 mm ventral to the bregma) [9]. The electrode
(FHC Inc., Bowddoin, ME, USA) was inserted in the MLR and fixed on the skull with anchor screws
and dental cement. A plug (GT-Labortechnik, Arnstein, Germany) was connected with the electrode
and attached with additional dental cement. After wound closure, animals were allowed to wake up.
4.4. High-Frequency Stimulation of the Mesencephalic Locomotor Region
Rats were divided randomly into a stimulated group (stim-group, n = 8) and a nonstimulated
group (sham group, n = 6). Three hours after photothrombosis onset, MLR-HFS (frequency; 130 Hz;
pulse length, 60 µs; monophasic square wave pulses) was begun in the stimulated group and continued
for 24 h using a stimulus generator (STG 4002, Multichannel Systems, Reutlingen, Germany). The
lowest current evoking locomotion was chosen for the 24 h MLR-HFS [9]. Simultaneously, rats of the
sham group were connected with the stimulus generator but no electrical stimulation was applied
during 24 h.
4.5. Collection of Cerebral Tissue
After injecting pentobarbital into the peritoneum, rats were perfused transcardially with phosphate
buffered saline and brains were removed. One millimeter before bregma, a brain section of 2 mm
thickness was cut. The cortex comprising the perilesional area, as well as the basal ganglia and the
corresponding contralateral regions, were dissected for further analysis.
4.6. Immunohistochemistry
Immunohistochemistry of cryo-embedded brain sections was performed using anti-albumin
(ab10685, abcam, Cambridge, UK), anti-von Willebrand factor (ab6994, abcam), anti-occludin (611090,
BD Transduction Laboratories, San Jose, CA, USA), and anti-claudin 5 (35-2500, Invitrogen, Waltham,
MA, USA) antibodies as described recently [22]. Quantification of the albumin-positive area was
carried out from 5 subsequent slices per animal with an interval of 100 µm (5-fold magnification).
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Claudin 5 and occludin staining were quantified using 40-fold magnification by measuring the length of
continuous (undisrupted) junctional lines in three optical fields within the regions of interest, applying
Image J software version 1.52j (NIH, Bethestda, MD, USA). DAPI staining was used to counterstain
cell nuclei and to quantify infarct volumes. Sections were analyzed under a microscope (Leica DMI 8,
Leica Microsystems, Wetzlar, Germany) equipped with a charge-coupled device camera.
4.7. Western Blot Assays
Western blot analysis was performed according to standard procedures using antibodies against
albumin (ab10685, Abcam), occludin (611090, BD Biosciences, San Jose, CA, USA), claudin 3 (34-1700,
Thermofisher, Waltgan, MA, USA) claudin 5 (sc-28670, Santa-Cruz, Dallas, TX, USA), and anti-β-actin
(A5441, Sigma-Aldrich, Darmstadt, Germany), exactly as described elsewhere [23].
4.8. Zymography
The amount of pro MMP-9 in brain lysates was detected by zymography according to standard
procedures, exactly as described elsewhere [24].
4.9. Statistical Analysis
For statistical analysis, the GraphPad Prism 5.0 software package (GraphPad Software, GraphPad,
San Diego, CA, USA) was used. Results are given as mean ± standard error of the mean. Data were
tested for Gaussian distribution with the D’Agostino and Pearson omnibus normality test and then
analyzed by unpaired, two-tailed Student’s t-test. To test for significant differences between multiple
groups, one-way analysis of variance was used, with post hoc Bonferroni adjustment for p-values. p <
0.05 was considered statistically significant.
5. Conclusions
In conclusion, MLR-HFS does not alleviate BBB dysfunction in the paradigm tested here. However,
electrical stimulation of distinct brain structures might still be an alternative to modulate BBB function,
even under pathological conditions such as ischemic stroke, and might be an additional therapeutic
option allowing a more targeted use, as it would be possible with a pharmacological therapy.
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